Lupine Publishers-Journal of Urology

Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Antagonists on Residual Renal Function Preservation in Peritoneal Dialysis Patients by Reyes Marin Fernando Arturo in Journal of Urology & Nephrology Studies in Lupine Publishers.

Angiotensin-converting enzyme inhibitors (ACEi) and angiotensin II receptor blockers (ARBs) are recommended in peritoneal dialysis (PD) patients for hypertension or heart failure control [1] Angiotensin II (AII) is an important factor in the development of renal fibrosis due to its hemodynamic effects on glomeruli and stimulation of extracellular matrix proteins synthesis, mediated by TGF b [2]. This may explain why treatment with ACEi and ARBs is renoprotective in patients with diabetic and non-diabetic nephropathy.

https://lupinepublishers.com/urology-nephrology-journal/fulltext/angiotensin-converting-enzyme-inhibitors-and-angiotensin-ii-receptor-antagonists-on-residual-renal-function-preservation-in-peritoneal-dialysis-patients.ID.000117.php

https://lupinepublishers.com/urology-nephrology-journal/pdf/JUNS.MS.ID.000117.pdf

https://lupinepublishers.com/urology-nephrology-journal/abstracts/angiotensin-converting-enzyme-inhibitors-and-angiotensin-ii-receptor-antagonists-on-residual-renal-function-preservation-in-peritoneal-dialysis-patients.ID.000117.php

For more Lupine Publishers Open Access Journals Please visit our website:http://www.lupinepublishers.com/

For more Journal of Nephrology articles Please Click Here: https://lupinepublishers.com/urology-nephrology-journal/index.php